Skip to main content
Figure 1 | Virology Journal

Figure 1

From: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation

Figure 1

Effects of anti-IL-17 cytokine therapy on survival rate. The survival rate of IL-17mAb group mice was significantly improved comparing with the isotype control and PBS groups (P < 0.05). No statistical difference was seen between the IL-17mAb and normal mice (P > 0.05). Eight mice in normal group, seven mice in IL-17mAb group, four mice in isotype control group and five mice in PBS group survived to 14 days.

Back to article page

Virology Journal

ISSN: 1743-422X